Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The polycystic ovary syndrome is a common cause of infertility. Clomiphene and insulin sensitizers are used alone and in combination to induce ovulation, but it is unknown whether one approach is superior. METHODS: We randomly assigned 626 infertile women with the polycystic ovary syndrome to receive clomiphene citrate plus placebo, extended-release metformin plus placebo, or a combination of metformin and clomiphene for up to 6 months. Medication was discontinued when pregnancy was confirmed, and subjects were followed until delivery. RESULTS: The live-birth rate was 22.5% (47 of 209 subjects) in the clomiphene group, 7.2% (15 of 208) in the metformin group, and 26.8% (56 of 209) in the combination-therapy group (P<0.001 for metformin vs. both clomiphene and combination therapy; P=0.31 for clomiphene vs. combination therapy). Among pregnancies, the rate of multiple pregnancy was 6.0% in the clomiphene group, 0% in the metformin group, and 3.1% in the combination-therapy group. The rates of first-trimester pregnancy loss did not differ significantly among the groups. However, the conception rate among subjects who ovulated was significantly lower in the metformin group (21.7%) than in either the clomiphene group (39.5%, P=0.002) or the combination-therapy group (46.0%, P<0.001). With the exception of pregnancy complications, adverse-event rates were similar in all groups, though gastrointestinal side effects were more frequent, and vasomotor and ovulatory symptoms less frequent, in the metformin group than in the clomiphene group. CONCLUSIONS: Clomiphene is superior to metformin in achieving live birth in infertile women with the polycystic ovary syndrome, although multiple birth is a complication. (ClinicalTrials.gov number, NCT00068861 [ClinicalTrials.gov].).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and there is no evidence-based need to continue metformin in these individuals (92)(93)(94).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [92]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These findings are consistent with previous systematic reviews comparing metformin to placebo with or without lifestyle.61,64,65”
From The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials (2023) · cites this paper as [64]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
ACOG Practice Bulletin No. 30: Gestational Diabetes
(2001) · Obstetrics & Gynecology · doi:10.1097/00006250-200109000-00037 · Cited by 301
RetractedThe Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Ehrmann, D. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041536 · Cited by 1,881
Maternal Morbid Obesity and the Risk of Adverse Pregnancy Outcome
Cedergren, M. I. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000107291.46159.00 · Cited by 1,248
Obesity, obstetric complications and cesarean delivery rate–a population-based screening study
Weiss, J. L., Malone, F. D., Emig, D., Ball, R. H., Nyberg, D. A., Comstock, C. H., Saade, G., Eddleman, K., Carter, S. M., Craigo, S. D., et al. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2003.09.058 · Cited by 1,138
Practice bulletin #33: diagnosis and management of preeclampsia and eclampsia
ACOG Committee on Obstetric Practice (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(01)01747-1 · Cited by 1,058
A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome
Boomsma, C. M., Eijkemans, M. J. C., Hughes, E. G., Visser, G. H. A., Fauser, B. C. J. M., & Macklon, N. S. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml036 · Cited by 852
Research works printed but not linked: 4
- Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific; 1992:377-84. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Re- vised 2003 consensus on diagnostic crite- ria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
- 2004, Fertil Steril, 81, 19
- The New England Journal of Medicine Downloaded from nejm.org on August 29, 2023. For personal use only. No other uses without permission. Copyright © 2007 Massachusetts Medical Society. All rights reserved. n engl j med 356;
- www.nejm.org february 8, 2007 566 Clomiphene versus Metformin in the Polycystic Ovary Syndrome ovary syndrome: a prospective parallel randomized double-blind placebo-con- trolled trial. J Clin Endocrinol Metab 2004; 89:4801-9. [Erratum, J Clin Endocrinol Metab 2005;90:3945.]
Cited by
Items 201–300 of 1,000
Dupont, J., Chabrolle, C., Ramé, C., Tosca, L., & Coyral-Castel, S. (2007) · PPAR Research · doi:10.1155/2008/176275 · Cited by 70
Polycystic Ovary Syndrome in the Adolescent
Pfeifer, S. M., & Kives, S. L. (2009) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2008.12.004 · Cited by 67
Dehydroepiandrosterone to induce murine models for the study of polycystic ovary syndrome
Motta, A. B. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.015 · Cited by 66
Effect of yoga on polycystic ovarian syndrome: A systematic review
Thakur, D., Singh, S. S., Tripathi, M., & Lufang, D. (2021) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2021.02.018 · Cited by 64
Potential Regulatory Functions of MicroRNAs in the Ovary
Toloubeydokhti, T., Bükülmez, O., & Chegini, N. (2008) · Seminars in Reproductive Medicine · doi:10.1055/s-0028-1096127 · Cited by 65
Endocrine Basis for Recurrent Pregnancy Loss
Ke, R. W. (2013) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2013.10.003 · Cited by 67
Liu, C., Feng, G., Huang, W., Wang, Q., Yang, S., Tan, J., Fu, J., & Liu, D. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1332174 · Cited by 67
Abdi, M., Pasbakhsh, P., Shabani, M., Nekoonam, S., Sadeghi, A., Fathi, F., Abouzaripour, M., Mohamed, W. M. Y., Zibara, K., Kashani, I. R., et al. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00417-y · Cited by 61
Best practices of ASRM and ESHRE: a journey through reproductive medicine
Gianaroli, L., Racowsky, C., Geraedts, J. P. M., Cedars, M. I., Makrigiannakis, A., & Lobo, R. A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.07.1164 · Cited by 68
The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome
Katsiki, N., Georgiadou, E., & Hatzitolios, A. I. (2009) · Drugs · doi:10.2165/00003495-200969110-00001 · Cited by 57
Current perspectives of insulin resistance and polycystic ovary syndrome
Pauli, J. M., Raja‐Khan, N., Wu, X., & Legro, R. S. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03460.x · Cited by 54
Self-citationHome, P. D., & Pacini, G. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00761.x · Cited by 54
Legro, R. S., Roller, R. L., Dodson, W. C., Stetter, C. M., Kunselman, A. R., & Dunaif, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1849 · Cited by 55
Self-citationEndometrial Shedding Effect on Conception and Live Birth in Women With Polycystic Ovary Syndrome
Diamond, M. P., Kruger, M., Santoro, N. F., Zhang, H., Casson, P. R., Schlaff, W. D., Coutifaris, C., Brzyski, R. G., Christman, G. M., Carr, B. R., et al. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31824da35c · Cited by 54
Self-citationSanchez-Garrido, M. A., Serrano-López, V., Ruíz-Pino, F., Vazquez, M. J., Rodríguez-Martín, A., Torres, E., Velasco, I., Rodríguez, A., Chicano‐Gálvez, E., Mora-Ortiz, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52898-y · Cited by 60
Soliman, G. M., Fetih, G. N., & Abbas, A. M. (2016) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2016.1254239 · Cited by 59
JOHNSON, N. (2011) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2010.01274.x · Cited by 53
DHEA-Mediated Inhibition of the Pentose Phosphate Pathway Alters Oocyte Lipid Metabolism in Mice
Jimenez, P. T., Frolova, A. I., Chi, M. M., Grindler, N. M., Willcockson, A. R., Reynolds, K. A., Zhao, Q., & Moley, K. H. (2013) · Endocrinology · doi:10.1210/en.2012-2140 · Cited by 52
Metformin: an old therapy that deserves a new indication for the treatment of obesity.
Igel, L. I., Sinha, A., Saunders, K. H., Apovian, C. M., Vojta, D., & Aronne, L. J. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0568-3 · Cited by 52
Kwon, C.-Y., Cho, I.-H., & Park, K. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01192 · Cited by 52
Arya, S., Hansen, K. R., Peck, J. D., & Wild, R. A. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.03.048 · Cited by 59
Use of metformin in the treatment of polycystic ovary syndrome
Genazzani, A. D., Ricchieri, F., & Lanzoni, C. (2010) · Women's Health · doi:10.2217/whe.10.43 · Cited by 51
Mono-ovulation in women with polycystic ovary syndrome: a clinical review on ovulation induction
Petersen, K. B., Pedersen, N. G., Pedersen, A. T., Lauritsen, M. P., & Freiesleben, N. L. C. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.03.006 · Cited by 54
Pharmacology of medications used for ovarian stimulation
Quaas, A. M., & Legro, R. S. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.10.002 · Cited by 55
Self-citationRetinol-Binding Protein 4 and Insulin Resistance in Polycystic Ovary Syndrome
Hutchison, S. K., Harrison, C., Stepto, N., Meyer, C., & Teede, H. J. (2008) · Diabetes Care · doi:10.2337/dc07-2265 · Cited by 51
Tang, T., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub3 · Cited by 51
Nybacka, Å., Hellström, P. M., & Hirschberg, A. L. (2017) · Clinical Endocrinology · doi:10.1111/cen.13427 · Cited by 50
The effects of microbiota on reproductive health: A review
Wang, N., Chen, L., Yi, K., Zhang, B., Li, C., & Zhou, X. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2117784 · Cited by 57
Morgante, G., Orvieto, R., Sabatino, A. D., Musacchio, M. C., & Leo, V. D. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.01.035 · Cited by 57
Pau, C. T., Keefe, C., Duran, J., & Welt, C. K. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4021 · Cited by 49
Peng, Y., Guo, L., Gu, A., Shi, B., Ren, Y.-K., Cong, J., & Yang, X. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00198-8 · Cited by 53
Diabetes and the Female Reproductive System
Nandi, A. A., & Poretsky, L. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.07.007 · Cited by 55
Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences
Yau, T., Ng, N. Y. H., Cheung, L., & Ronald, C. W. (2017) · Hong Kong Medical Journal · doi:10.12809/hkmj176308 · Cited by 60
Contemporary approaches to the management of polycystic ovary syndrome
Pasquali, R. (2018) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818756790 · Cited by 63
Rah, H., Jeon, Y. J., Shim, S. H., Cha, S. H., Choi, D. H., Kwon, H., Kim, J. H., Shin, J. E., & Kim, N. K. (2012) · Reproductive Sciences · doi:10.1177/1933719112450341 · Cited by 54
Fulghesu, A. M., Romualdi, D., Di Florio, C., Sanna, S., Tagliaferri, V., Gambineri, A., Tomassoni, F., Minerba, L., Pasquali, R., & Lanzone, A. (2012) · Human Reproduction · doi:10.1093/humrep/des262 · Cited by 48
“The most commonly reported side effects are nausea, vomiting and gastrointestinal distress, such as diarrhoea, flatulence and abdominal discomfort (Legro et al., 2007; Tang et al., 2012).”
BackgroundWu, X.-K., Wang, Y., Liu, J., Liang, R.-N., Xue, H.-Y., Ma, H.-X., Shao, X., Ng, E. H. Y., Hou, L., Wang, Y.-Y., et al. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.022 · Cited by 57
Martinuzzi, K., Ryan, S., Luna, M., & Copperman, A. B. (2008) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-008-9213-6 · Cited by 59
Billa, E., Kapolla, N., Nicopoulou, S., Koukkou, E. G., Venaki, E., Milingos, S., Antsaklis, A. J., & Adamopoulos, D. A. (2009) · Gynecological Endocrinology · doi:10.1080/09513590902770172 · Cited by 48
Moll, E., Korevaar, J. C., Bossuyt, P. M. M., & van der Veen, F. (2008) · Human Reproduction · doi:10.1093/humrep/den182 · Cited by 50
Jensterle, M., Janez, A., Mlinar, B., Marc, J., Prezelj, J., & Pfeifer, M. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0857 · Cited by 47
Jungheim, E. S., & Odibo, A. O. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.077 · Cited by 51
Siebert, T. I., Viola, M. I., Steyn, D. W., & Kruger, T. F. (2012) · Gynecologic and Obstetric Investigation · doi:10.1159/000335253 · Cited by 46
Polycystic Ovary Syndrome and Insulin: Our Understanding in the Past, Present and Future
Mayer, S., Evans, W. S., & Nestler, J. E. (2015) · Women s Health · doi:10.2217/whe.14.73 · Cited by 60
Self-citationInsulin resistance and fertility in polycystic ovary syndrome.
Fica, S. V., Albu, A. I., Constantin, M., & Dobri, G. A. (2008) · Journal of Medicine and Life · Cited by 55
An RCT of metformin versus orlistat for the management of obese anovulatory women
Metwally, M., Amer, S., Li, T. C., & Ledger, W. L. (2008) · Human Reproduction · doi:10.1093/humrep/den454 · Cited by 47
Bolton, S., Cleary, B., Walsh, J., Dempsey, E., & Turner, M. J. (2009) · European Journal of Pediatrics · doi:10.1007/s00431-008-0737-7 · Cited by 45
Mvondo, M. A., Tsoplfack, F. I. M., Awounfack, C. F., & Njamen, D. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-03070-8 · Cited by 46
Unlicensed use of metformin in children and adolescents in the UK
Hsia, Y., Dawoud, D., Sutcliffe, A. G., Viner, R. M., Kinra, S., & Wong, I. C. K. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04063.x · Cited by 44
Twenty years of ovulation induction with metformin for PCOS; what is the best available evidence?
Hashim, H. A. (2015) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2015.09.015 · Cited by 54
Relationship between Recurrent Miscarriage and Insulin Resistance
Wang, Y., Zhao, H., Li, Y., Zhang, J., Tan, J., & Liu, Y. (2011) · Gynecologic and Obstetric Investigation · doi:10.1159/000325165 · Cited by 48
Insulin resistance and the long-term consequences of polycystic ovary syndrome
Bhathena, R. K. (2011) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2010.539722 · Cited by 43
van Oers, A. M., Groen, H., Mutsaerts, M. A. Q., Burggraaff, J. M., Kuchenbecker, W. K. H., Perquin, D. A. M., Koks, C. A. M., van Golde, R., Kaaijk, E. M., Schierbeek, J. M., et al. (2016) · Human Reproduction · doi:10.1093/humrep/dew252 · Cited by 43
Palomba, S., Falbo, A. I., Orio, F., Tolino, A., & Zullo, F. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.03.011 · Cited by 48
Best practices of ASRM and ESHRE: a journey through reproductive medicine
Gianaroli, L., Racowsky, C., Geraedts, J. P. M., Cedars, M. I., Makrigiannakis, A., & Lobo, R. A. (2012) · Human Reproduction · doi:10.1093/humrep/des338 · Cited by 49
A Novel System Dynamics Model of Female Obesity and Fertility
Sabounchi, N. S., Hovmand, P. S., Osgood, N. D., Dyck, R. F., & Jungheim, E. S. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.301898 · Cited by 55
Metformin for the Treatment of Hyperandrogenism in Adolescents with Type 1 Diabetes Mellitus
Codner, E., Iñíguez, G., López, P., Mujica, V., Eyzaguirre, F. C., Asenjo, S., Torrealba, I., & Cassorla, F. (2013) · Hormone Research in Paediatrics · doi:10.1159/000355513 · Cited by 42
Sood, M., Zweig, S. B., Tolentino, M. C., Strizhevsky, M., & Poretsky, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_33 · Cited by 44
Reproductive impact of polycystic ovary syndrome
Usadi, R., & Legro, R. S. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328359ff92 · Cited by 47
Self-citationAndrogens and Insulin – Two Key Players in Polycystic Ovary Syndrome
Schüring, A. N., Schulte, N., Sonntag, B., & Kiesel, L. (2008) · Gyn�kologisch-geburtshilfliche Rundschau · doi:10.1159/000111465 · Cited by 53
Recent thoughts on management and prevention of recurrent early pregnancy loss
Tang, A.-W., & Quenby, S. M. (2010) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e32833e124e · Cited by 46
Hurst, B. S., Hickman, J. M., Matthews, M. L., Usadi, R., & Marshburn, P. B. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.10.031 · Cited by 46
Targher, G. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1610000 · Cited by 40
Infertility Evaluation and Treatment
Santoro, N., & Polotsky, A. J. (2025) · New England Journal of Medicine · doi:10.1056/nejmcp2311150 · Cited by 45
Aromatase inhibitors for ovulation induction and ovarian stimulation
Lee, V. C. Y., & Ledger, W. J. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04006.x · Cited by 49
Off-label drug use in the treatment of polycystic ovary syndrome
Vitek, W., Alur-Gupta, S., & Hoeger, K. M. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.01.019 · Cited by 47
Magzoub, R., Kheirelseid, E. A. H., Perks, C. M., & Lewis, S. J. (2022) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2022.01.025 · Cited by 49
What every physician should know about polycystic ovary syndrome
Rosenfield, R. L. (2008) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2008.00217.x · Cited by 47
Hamed, H. O., Hasan, A. F., Ahmed, O. G., & Ahmed, M. A. (2010) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.08.033 · Cited by 41
RetractedPolycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J., & Dumesic, D. A. (2019) · Yen and Jaffe's Reproductive Endocrinology · doi:10.1016/b978-0-323-47912-7.00021-4 · Cited by 36
Gestational Weight Gain in Women With Polycystic Ovary Syndrome: A Controlled Study
Kent, J., Dodson, W. C., Kunselman, A., Pauli, J., Stone, A., Diamond, M. P., Coutifaris, C., Schlaff, W. D., Alvero, R., Casson, P., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02764 · Cited by 41
Self-citationAbdellah, M. S. (2011) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2010.11.026 · Cited by 41
RetractedPolycystic ovary syndrome: chemical pharmacotherapy
Rocca, M. L., Venturella, R., Mocciaro, R., Cello, A. D., Sacchinelli, A., Russo, V. M., Trapasso, S., Zullo, F., & Morelli, M. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1047344 · Cited by 43
Prevalence and ultrasound features of polycystic ovaries in young unmarried Saudi females
Guraya, S. (2013) · Journal of Microscopy and Ultrastructure · doi:10.1016/j.jmau.2013.06.002 · Cited by 50
Physiology and Pathology of the Female Reproductive Axis
Bulun, S. E. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00017-1 · Cited by 49
Preiss, D., Sattar, N., Harborne, L., Norman, J., & Fleming, R. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01825.x · Cited by 39
When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
Franks, S. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03934.x · Cited by 46
Diagnosis and Treatment of Polycystic Ovary Syndrome
Lee, H., & Sung, Y. (2007) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2007.22.4.252 · Cited by 39
Hager, M., Nouri, K., Imhof, M., Egarter, C., & Ott, J. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-019-05194-w · Cited by 35
Wang, C., Ding, C., Hua, Z., Chen, C.-Y., & Jia, Y. (2020) · Mediators of Inflammation · doi:10.1155/2020/8865647 · Cited by 42
Management strategy of infertility in polycystic ovary syndrome
Li, M., Ruan, X., & Mueck, A. O. (2022) · Global Health Journal · doi:10.1016/j.glohj.2022.03.002 · Cited by 48
Shao, R., Nutu, M., Weijdegård, B., Egecioglu, E., Fernández-Rodríguez, J., Karlsson-Lindahl, L., Gemzell‐Danielsson, K., Bergh, C., & Billig, H. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.108.074237 · Cited by 40
Fadlalmola, H. A., Elhusein, A. M., Al‐Sayaghi, K. M., Albadrani, M. S., Swamy, D. S. V., Mamanao, D. M., El-Amin, E. I., Ibrahim, S. E., & Abbas, S. M. (2023) · Pan African Medical Journal · doi:10.11604/pamj.2023.44.134.32404 · Cited by 47
Xie, L., Zhang, D., Ma, H., He, H. R., Xia, Q., Shen, W., Chang, H., Deng, Y., Wu, Q., Cong, J., et al. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/7918631 · Cited by 43
Physiology of the female reproductive axis
Bates, G. W., & Bowling, M. R. (2012) · Periodontology 2000 · doi:10.1111/j.1600-0757.2011.00409.x · Cited by 48
Polycystic ovary syndrome update in adolescence
Hassan, A., & Gordon, C. M. (2007) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328236743f · Cited by 38
Cardiometabolic abnormalities in the polycystic ovary syndrome: Pharmacotherapeutic insights
Westerveld, H. E., Hoogendoorn, M., de Jong, A. W. F., Goverde, A. J., Fauser, B. C. J. M., & Dallinga‐Thie, G. M. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.04.009 · Cited by 39
Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome
Dungan, J. S. (2008) · Yearbook of Obstetrics Gynecology and Women s Health · doi:10.1016/s1090-798x(08)79050-7 · Cited by 38
Ibáñez, L., López-Bermejo, A., Callejo, J., Torres, A., Cabré, S., Dunger, D., & de Zegher, F. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1800 · Cited by 38
PCOS: diagnosis and management of related infertility
Chami, A. A., O'Donovan, O., & Davies, M. C. (2015) · Obstetrics Gynaecology & Reproductive Medicine · doi:10.1016/j.ogrm.2015.07.005 · Cited by 29
Feto-maternal outcomes and Glycemic control in Metforminversus insulin treated Gestational Diabetics
Arshad, R., Khanam, S., SHAIKH, D. F., & Karim, D. N. (2017) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.335.13286 · Cited by 37
Kar, S., & Sanchita, S. (2015) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.170373 · Cited by 36
Successful weight loss interventions before in vitro fertilization: fat chance?
Norman, R. J., & Mol, B. W. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.05.029 · Cited by 38
Direct toxicity of insulin on the human placenta and protection by metformin
Vega, M., Mauro, M., & Williams, Z. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.11.032 · Cited by 41
Farhi, J., Orvieto, R., Gavish, O., & Homburg, R. (2010) · Gynecological Endocrinology · doi:10.3109/09513591003686312 · Cited by 36
Veltman-Verhulst, S. M., Fauser, B. C. J. M., & Eijkemans, M. J. C. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.04.027 · Cited by 36
Richardson, M. C., Ingamells, S., Simonis, C. D., Cameron, I. T., Sreekumar, R., Vijendren, A., Sellahewa, L., Coakley, S., & Byrne, C. D. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2025 · Cited by 36
Jung, W., Choi, H., Kim, J., Kim, J., Kim, W., Nurkolis, F., & Kim, B. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20889 · Cited by 36
Targeting insulin sensitivity in the treatment of polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903190699 · Cited by 35
Stress Induces AMPK-Dependent Loss of Potency Factors Id2 and Cdx2 in Early Embryos and Stem Cells
Xie, Y., Awonuga, A. O., Liu, J., Rings, E. H. H. M., Puscheck, E. E., & Rappolee, D. A. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0352 · Cited by 37
Metadata
- Authors
- Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., Gosman, G. G., Nestler, J. E., Giudice, L. C., Leppert, P. C., & Myers, E. R.
- Affiliations
- Pennsylvania State University (US)
- Duke Medical Center (US)
- University of Colorado Denver (US)
- The University of Texas Southwestern Medical Center (US)
- Wayne State University (US)
- Baylor College of Medicine (US)
- University of Alabama at Birmingham (US)
- University of Pennsylvania (US)
- University of Medicine and Dentistry of New Jersey (US)
- Stanford University (US)
- University of Pittsburgh (US)
- Virginia Commonwealth University (US)
- University of California, San Francisco (US)
- National Institutes of Health (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-02-08
- Volume
- 356
- Issue
- 6
- Pages
- 551-566
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2138595862
- Cited by
- 1,027
- References
- 37
- Citations by year
- 2026: 17 · 2025: 23 · 2024: 32 · 2023: 41 · 2022: 50 · 2021: 43 · 2020: 35 · 2019: 36 · 2018: 39 · 2017: 59 · 2016: 46 · 2015: 64 · 2014: 46 · 2013: 68 · 2012: 63
- FWCI
- 107.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- VCU Scholars Compass (Virginia Commonwealth University) (submittedVersion)
- Funders
- National Institutes of Health
- National Center for Research Resources (M01-RR00056, M01 RR10732, C06RR016499, M01RR000056, M01RR010732)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U10HD033172, U10HD038999, U54-HD29834, U10HD27049, U10HD039005, U10-HD38992, U10 HD27011, U10-HD39005, U10HD027011, U10 HD38999, U10HD038998, U01HD038997, U10-HD38998, U01-HD38997, U10-HD38988, U10HD038988, U10HD027049, U10 HD33172, U10HD038992)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, infertility, clomiphene citrate, metformin, ovulation induction, live birth rate, multiple pregnancy, conception rate, early pregnancy loss, insulin sensitizers, combination therapy
- MeSH terms
- Adult, Birth Rate, Clomiphene, Drug Therapy, Combination, Female, Fertility Agents, Female, Humans, Hypoglycemic Agents, Infertility, Female, Metformin, Ovulation Induction, Patient Compliance, Polycystic Ovary Syndrome, Pregnancy, Pregnancy Complications, Pregnancy, Multiple, Live Birth, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.